A Strategy of Killing Three Birds with One Stone for
Cancer Therapy through Regulating the Tumor Microenvironment by H2O2‑Responsive Gene Delivery System
posted on 2019-12-11, 16:11authored byHuapan Fang, Jie Chen, Lin Lin, Feng Liu, Huayu Tian, Xuesi Chen
Constructing an efficient in vivo gene delivery
system has always been extremely challenging. Herein, a highly efficient
H2O2-responsive in vivo polycationic gene delivery
system is developed for the first time. The efficient vector PLL-RT
(i.e., polylysine grafted with p-tosyl-l-arginine) is used to mediate plasmid DNA (pDNA) delivery, and H2O2-responsive thioketal dipropanedioic acid-modified
dextran (TDPAD) is used as a shielding system for effectively coating
vector/pDNA polyplexes. The constructed gene delivery system exhibits
a prolonged circulatory half-life in vivo and accelerates the accumulation
of vector/DNA polyplexes in tumor tissue by the enhanced permeability
and retention (EPR) effect. Moreover, this gene delivery system exhibits
highly efficient and synergistic antitumor effects through a strategy
of killing three birds with one stone. First, upon the arrival of
TDPAD/PLL-RT/pDNA [abbreviated as T(PD)] at the tumor site by the
EPR effect, TDPAD reacts with excess H2O2 in
tumor tissue, contributing to the detachment of TDPAD, and PLL-RT
then mediates the enhanced endocytosis of pDNA encoding shVEGF and
significantly downregulates the expression of vascular endothelial
growth factor (VEGF) in tumor tissue, exhibiting an outstanding antitumor
effect. Second, the H2O2 consumption by TDPAD
significantly decreases the H2O2 level in tumor
tissue, which synergistically suppresses tumor growth. Third, small-molecule
product mercaptopropionic acid, generated by the reaction of TDPAD
with H2O2, can induce cancer cell apoptosis
and exert pronounced antitumor efficacy. This polycationic gene delivery
system shows negligible toxicity in vitro and in vivo. This strategy
provides an ideal platform for constructing an efficient in vivo gene
delivery system and has bright prospects for cancer therapy.